Aggregate de-identified oncology patient data from EHRs for research, quality improvement, and clinical decision-making.
Key Activities
High-quality patient datasets for use by researchers, nonprofits, providers, and government agencies; QOPI quality measure tracking and reporting with SmartLinQ.
CancerLinQ was developed and launched by ASCO in 2013 as a real-world oncology data platform and was acquired by ConcertAI in December 2023.